Literature DB >> 9098659

The System of Objectified Judgement Analysis (SOJA). A tool in rational drug selection for formulary inclusion.

R Janknegt1, A Steenhoek.   

Abstract

Rational drug selection for formulary purposes is important. Besides rational selection criteria, other factors play a role in drug decision making, such as emotional, personal financial and even unconscious criteria. It is agreed that these factors should be excluded as much as possible in the decision making process. A model for drug decision making for formulary purposes is described, the System of Objectified Judgement Analysis (SOJA). In the SOJA method, selection criteria for a given group of drugs are prospectively defined and the extent to which each drug fulfils the requirements for each criterion is determined. Each criterion is given a relative weight, i.e. the more important a given selection criterion is considered, the higher the relative weight. Both the relative scores for each drug per selection criterion and the relative weight of each criterion are determined by a panel of experts in this field. The following selection criteria are applied in all SOJA scores: clinical efficacy, incidence and severity of adverse effects, dosage frequency, drug interactions, acquisition cost, documentation, pharmacokinetics and pharmaceutical aspects. Besides these criteria, group specific criteria are also used, such as development of resistance when a SOJA score was made for antimicrobial agents. The relative weight that is assigned to each criterion will always be a subject of discussion. Therefore, interactive software programs for use on a personal computer have been developed, in which the user of the system may enter their own personal relative weight to each selection criterion and make their own personal SOJA score. The main advantage of the SOJA method is that all nonrational selection criteria are excluded and that drug decision making is based solely on rational criteria. The use of the interactive SOJA discs makes the decision process fully transparent as it becomes clear on which criteria and weighting decisions are based. We have seen that the use of this method for drug decision making greatly aids the discussion in the formulary committee, as discussion becomes much more concrete. The SOJA method is time dependent. Documentation on most products is still increasing and the score for this criterion will therefore change continuously. New products are introduced and prices are also subject to change. To overcome the time-dependence of the SOJA method, regular updates of interactive software programs are being made, in which changes in acquisition cost, documentation or a different weighting of criteria are included, as well as newly introduced products. The possibility of changing the official acquisition cost into the actual purchasing costs for the hospital in question provides a tailor-made interactive program.

Mesh:

Year:  1997        PMID: 9098659     DOI: 10.2165/00003495-199753040-00002

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


  18 in total

1.  RXPERT: a prototype expert system for formulary decision making.

Authors:  M L Greer
Journal:  Ann Pharmacother       Date:  1992-02       Impact factor: 3.154

2.  There is no such thing as a free lunch. Developing policies on pharmaceutical industry support.

Authors:  W Newton; A Goldstein; J Frey
Journal:  J Fam Pract       Date:  1992-01       Impact factor: 0.493

3.  Physicians' behavior and their interactions with drug companies. A controlled study of physicians who requested additions to a hospital drug formulary.

Authors:  M M Chren; C S Landefeld
Journal:  JAMA       Date:  1994-03-02       Impact factor: 56.272

4.  Influencing prescriber behavior.

Authors:  W A Zellmer
Journal:  Am J Hosp Pharm       Date:  1990-07

Review 5.  Fluoroquinolones: use of clinical data to aid formulary choice by the system of objective judgement analysis (SOJA) method.

Authors:  R Janknegt
Journal:  Pharmacoeconomics       Date:  1994-07       Impact factor: 4.981

6.  [The decision making process of the family physician in choosing a drug].

Authors:  B Wierenga; S J Jong; A F Mantel
Journal:  Ned Tijdschr Geneeskd       Date:  1989-01-21

7.  An international perspective on antimicrobial resistance.

Authors:  B Wiedemann
Journal:  Am J Med       Date:  1995-12-29       Impact factor: 4.965

8.  Consensus conferences as drug promotion.

Authors:  T A Sheldon; G D Smith
Journal:  Lancet       Date:  1993-01-09       Impact factor: 79.321

9.  Multiattribute evaluation in formulary decision making as applied to calcium-channel blockers.

Authors:  G E Schumacher
Journal:  Am J Hosp Pharm       Date:  1991-02

10.  Pharmacodynamics of intravenous ciprofloxacin in seriously ill patients.

Authors:  A Forrest; D E Nix; C H Ballow; T F Goss; M C Birmingham; J J Schentag
Journal:  Antimicrob Agents Chemother       Date:  1993-05       Impact factor: 5.191

View more
  14 in total

1.  Drug and Therapeutics (D & T) committees in Dutch hospitals: a nation-wide survey of structure, activities, and drug selection procedures.

Authors:  R Fijn; J R Brouwers; R J Knaap; L T De Jong-Van Den Berg
Journal:  Br J Clin Pharmacol       Date:  1999-08       Impact factor: 4.335

2.  Dutch hospital drug formularies: pharmacotherapeutic variation and conservatism, but concurrence with national pharmacotherapeutic guidelines.

Authors:  R Fijn; S A Engels; J R Brouwers; R J Knaap; L T De Jong-Van den Berg
Journal:  Br J Clin Pharmacol       Date:  2000-03       Impact factor: 4.335

3.  The quality of Dutch hospital drug formularies: evaluation of technical features and organisational information.

Authors:  R Fijn; C S de Vries; S A Engels; J R Brouwers; C J de Blaey; L T de Jong-van den Berg
Journal:  Pharm World Sci       Date:  1999-06

Review 4.  Medication errors: hospital pharmacist perspective.

Authors:  Henk-Jan Guchelaar; Hadewig B B Colen; Mathijs D Kalmeijer; Patrick T W Hudson; Irene M Teepe-Twiss
Journal:  Drugs       Date:  2005       Impact factor: 9.546

5.  Impact of Modified System of Objectified Judgement Analysis (SOJA) methodology on prescribing costs of ACE inhibitors.

Authors:  Ibrahim Alabbadi; Grainne Crealey; Michael Scott; Simon Baird; Tom Trouton; Jill Mairs; James McElnay
Journal:  Clin Drug Investig       Date:  2006       Impact factor: 2.859

6.  From a to z: medication cost-management strategies for disproportionate share hospitals.

Authors:  Andrea Henry; Goldina Ikezuagu Erowele; Uche Anadu Ndefo; Jackie Milton-Brown; Enock Anassi; Wendy Green; Adriana Alvidrez; Alphonsus U Okpara
Journal:  Am Health Drug Benefits       Date:  2011-05

Review 7.  Formulary management of proton pump inhibitors.

Authors:  M F Byrne; F E Murray
Journal:  Pharmacoeconomics       Date:  1999-09       Impact factor: 4.981

8.  Method Development for Clinical Comprehensive Evaluation of Pediatric Drugs Based on Multi-Criteria Decision Analysis: Application to Inhaled Corticosteroids for Children with Asthma.

Authors:  Yuncui Yu; Lulu Jia; Yao Meng; Lihua Hu; Yiwei Liu; Xiaolu Nie; Meng Zhang; Xuan Zhang; Sheng Han; Xiaoxia Peng; Xiaoling Wang
Journal:  Paediatr Drugs       Date:  2018-04       Impact factor: 3.022

Review 9.  Practical differences between luteinizing hormone-releasing hormone agonists in prostate cancer: perspectives across the spectrum of care.

Authors:  Davide Meani; Mladen Solarić; Harri Visapää; Rose-Marie Rosén; Robert Janknegt; Majana Soče
Journal:  Ther Adv Urol       Date:  2017-11-23

10.  Do medical students copy the drug treatment choices of their teachers or do they think for themselves?

Authors:  J Tichelaar; M C Richir; H J Avis; H J Scholten; N F Antonini; Th P G M De Vries
Journal:  Eur J Clin Pharmacol       Date:  2009-11-24       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.